Search Result "soluble interleukin-6 receptor"
Immunotherapeutic Interleukin-6 or Interleukin-6 Receptor Blockade in Cancer: Challenges and Opportunities
Journal: Current Medicinal Chemistry
Volume: 25 Issue: 36 Year: 2018 Page: 4785-4806
Author(s): Nirmala Chandralega Kampan,Sue D. Xiang,Orla M. McNally,Andrew N. Stephens,Michael A. Quinn,Magdalena Plebanski
Cardiovascular Biology of Interleukin-6
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 1 Year: 2009 Page: 1809-1821
Author(s): Mahinda Y. Abeywardena, Wayne R. Leifert, Kirsty E. Warnes, Jose N. Varghese, Richard J. Head
Appreciating the Balance between Classical Interleukin (IL)-6 Receptor Signaling and IL-6 Trans-Signaling: Implications for Arthritis Progression
Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 8 Issue: 3 Year: 2008 Page: 235-246
Author(s): Simon A. Jones, Gareth W. Jones, Anwen S. Williams, Mari A. Nowell
Anti-Interleukin-6 Therapy for Crohns Disease
Journal: Current Pharmaceutical Design
Volume: 9 Issue: 4 Year: 2003 Page: 295-305
Author(s): H. Ito
Interleukin-6 Trans-Signaling and Colonic Cancer Associated with Inflammatory Bowel Disease
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 1 Year: 2009 Page: 2095-2103
Author(s): Stefan Rose-John, Keiichi Mitsuyama, Satoshi Matsumoto, Wolfgang M. Thaiss, Jurgen Scheller
Interleukin-6/interleukin-6 Receptor Pathway as a New Therapy Target in Epithelial Ovarian Cancer
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 25 Year: 2012 Page: 3816-3827
Author(s): Eveline M. Dijkgraaf,Marij J.P. Welters,Johan W.R. Nortier,Sjoerd H. van der Burg,Judith R. Kroep
Interleukin-6 In Rheumatoid Arthritis - From The Laboratory To The Bedside
Journal: Current Pharmaceutical Design
Volume: 21 Issue: 1 Year: 2015 Page: 2187-2197
Author(s): Xiao Liu, Andrew J. Teichtahl, Ian P. Wicks
Therapeutic Implications of Tocilizumab, A Humanized Anti-Interleukin-6 Receptor Antibody, for Various Immune-Mediated Diseases: An Update Review
Journal: Current Rheumatology Reviews
Volume: 8 Issue: 3 Year: 2012 Page: 209-226
Author(s): Toshio Tanaka,Atsushi Ogata,Yoshihito Shima,Masashi Narazaki,Atsushi Kumanogoh,Tadamitsu Kishimoto
IL-6 Signaling and its Blockade with a Humanized Anti-Interleukin-6 Receptor Antibody in Rheumatoid Arthritis: Advent of a New and Innovative Therapeutic Drug, Tocilizumab
Journal: Current Rheumatology Reviews
Volume: 7 Issue: 4 Year: 2011 Page: 288-300
Author(s): Yoshiyuki Ohsugi, Tadamitsu Kishimoto
Anti-Interleukin-6 Receptor Antibody Therapy in Rheumatic Diseases
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 6 Issue: 4 Year: 2006 Page: 373-381
Author(s): Hideko Nakahara, Norihiro Nishimoto